source
- U.S. Treasury Considers New Screening Rules for Investments in Chinese BiotechTreasury Department officials are reviewing possible measures to screen U.S. capital flowing into Chinese biotechnology firms, according to multiple sources familiar with the discussions. The revi…
- Eli Lilly stops 340B discounts for dozens of hospitals that did not submit claims dataEli Lilly has begun removing the federally mandated 340B price discounts for a few dozen hospitals that have not provided the required claims data. The company said the step follows a warning it is…